NYSE:NBY
NovaBay Pharmaceuticals, Inc Stock News
$0.0770
+0.0045 (+6.21%)
At Close: Apr 23, 2024
NovaBay Pharmaceuticals Announces Laboratory Results Confirm Avenova Kills SARS-CoV-2 (COVID-19 Virus)
12:00am, Monday, 13'th Jul 2020
NovaBay Pharmaceuticals Announces Laboratory Results Confirm Avenova Kills SARS-CoV-2
UPDATE: TLF Bio To Pay NovaBay Monthly Fee Of $37.5K During Term Of Deal; TLF Sold 1K Shares of NovaBay Stock
08:41pm, Monday, 18'th May 2020NovaBay Pharmaceuticals Issues Letter to Stockholders
10:50am, Thursday, 14'th May 2020
NovaBay Pharmaceuticals CEO Justin Hall issues Letter to Stockholders
NovaBay Pharmaceuticals Issues Letter to Stockholders
12:00am, Thursday, 14'th May 2020
NovaBay Pharmaceuticals CEO Justin Hall issues Letter to Stockholders
Coloplast ASB (CLPBF) CEO Kristian Villumsen on Q2 2020 Results - Earnings Call Transcript
04:42am, Monday, 11'th May 2020
Coloplast ASB (OTCPK:CLPBF) Q2 2020 Earnings Conference Call May 6, 2020 09:00 ET Company Participants Kristian Villumsen - Chief Executive Officer Anders Lonni
NovaBay Pharmaceuticals Q1 EPS $(0.060) Beats $(0.070) Estimate, Sales $1.900M Miss $2.090M Estimate
09:00pm, Thursday, 07'th May 2020NovaBay Pharmaceuticals Reports First Quarter 2020 Financial Results
08:05pm, Thursday, 07'th May 2020
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three months ended March 31, 2020 and provides a business update.
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
CORRECTING and REPLACING NovaBay Pharmaceuticals Appoints Andrew D. Jones Chief Financial Officer
06:05pm, Tuesday, 05'th May 2020
Please replace the release with the following revised version, which includes a change in the effective date in the first paragraph, first sentence to May 4, 2020.
NovaBay Pharmaceuticals Appoints Andrew D. Jones Chief Financial Officer
12:00am, Tuesday, 05'th May 2020
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces the appointment of Andrew D. Jones as Chief Financial Officer and Treasurer, effective M
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
